|
"wen chien chou"的相關文件
顯示項目 6-15 / 174 (共18頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2022-04-26T08:31:15Z |
PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients
|
Lee, Sze-Hwei; Lin, Chien-Chin; Wei, Chao-Hong; Chang, Ko-Ping; Yuan, Chang-Tsu; Tsai, Cheng-Hong; Liu, Jia-Hao; Hou, Hsin-An; Tang, Jih-Lu; WEN-CHIEN CHOU; Tien, Hwei-Fang |
| 臺大學術典藏 |
2022-04-26T08:29:09Z |
Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndrome
|
Wang, Yu-Hung; Lin, Chien-Chin; CHI-YUAN YAO; Hsu, Chia-Lang; Tsai, Cheng-Hong; Hou, Hsin-An; WEN-CHIEN CHOU; Tien, Hwei-Fang |
| 臺大學術典藏 |
2022-04-26T08:26:49Z |
Effectiveness of induction regimens on survival outcome in acute myeloid leukemia patients: a real-world data from 2001 to 2015
|
Hou, Hsin-An; Tzeng, Huey-En; Liu, Hung-Yi; WEN-CHIEN CHOU; Tien, Hwei-Fang; Chien, Li-Nien |
| 臺大學術典藏 |
2022-04-26T08:24:46Z |
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
|
Tien, Feng-Ming; Tsai, Cheng-Hong; Huang, Sheng-Chuan; Liu, Jia-Hau; Chen, Chien-Yuan; Kuo, Yuan-Yeh; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; Lin, Liang-In; Wu, Yu-Sin; Hou, Mei-Fang; Wu, Shang-Ju; SZU-CHUN HSU; Ko, Bor-Sheng; WEN-CHIEN CHOU; MING YAO; Hou, Hsin-An; Tang, Jih-Luh; Tien, Hwei-Fang |
| 臺大學術典藏 |
2022-04-26T08:21:05Z |
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang, Yu-Wen; Tsai, Xavier Cheng-Hong; Hou, Hsin-An; Tien, Feng-Ming; Liu, Jia-Hau; WEN-CHIEN CHOU; Ko, Bor-Sheng; Chen, Yu-Wen; Lin, Chien-Chin; Cheng, Chieh-Lung; Lo, Min-Yen; Lin, Yun-Chu; Lu, Li-Chun; Wu, Shang-Ju; Kuo, Sung-Hsin; Hong, Ruey-Long; Huang, Tai-Chung; MING YAO |
| 臺大學術典藏 |
2022-04-26T08:18:46Z |
Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients
|
Huang, Shang-Yi; Lin, Hsiu-Hsia; MING YAO; Tang, Jih-Luh; Wu, Shang-Ju; WEN-CHIEN CHOU; SZU-CHUN HSU; Ko, Bor-Sheng; Tien, Hwei-Fang |
| 臺大學術典藏 |
2022-04-26T08:16:16Z |
Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair
|
Chen, Tsung-Chih; CHI-YUAN YAO; Chen, Yu-Ren; Yuan, Chang-Tsu; Lin, Chien-Chin; Hsu, Yueh-Chwen; Chuang, Po-Han; Kao, Chein-Jun; Li, Yi-Hung; Hou, Hsin-An; WEN-CHIEN CHOU; Tien, Hwei-Fang |
| 臺大學術典藏 |
2022-02-14T23:55:23Z |
Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair
|
Chen, Tsung Chih; CHI-YUAN YAO; Chen, Yu Ren; Yuan, Chang Tsu; CHIEN-CHIN LIN; Hsu, Yueh Chwen; Chuang, Po Han; Kao, Chein Jun; Li, Yi Hung; HSIN-AN HOU; WEN-CHIEN CHOU; HWEI-FANG TIEN |
| 臺大學術典藏 |
2022-01-25T05:32:21Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
CHENG-HONG TSAI; JIH-LUH TANG; Tien, Feng Ming; YUAN-YEH KUO; Wu, Dung Chi; CHIEN-CHIN LIN; Tseng, Mei Hsuan; Peng, Yen Ling; Hou, Mei Fang; Chuang, Yi Kuang; Liu, Ming Chih; CHIA-WEN LIU; MING YAO; LIANG-IN LIN; WEN-CHIEN CHOU; CHIEN-YU CHEN; HSIN-AN HOU; HWEI-FANG TIEN |
| 臺大學術典藏 |
2022-01-10T08:54:12Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
CHENG-HONG TSAI; JIH-LUH TANG; Tien, Feng Ming; YUAN-YEH KUO; Wu, Dung Chi; CHIEN-CHIN LIN; Tseng, Mei Hsuan; Peng, Yen Ling; Hou, Mei Fang; Chuang, Yi Kuang; Liu, Ming Chih; CHIA-WEN LIU; MING YAO; LIANG-IN LIN; WEN-CHIEN CHOU; CHIEN-YU CHEN; HSIN-AN HOU; HWEI-FANG TIEN |
顯示項目 6-15 / 174 (共18頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
